Home » Topics » BioWorld Science

BioWorld Science
RSS

Immutep submits IND to begin phase II study of eftilagimod with Keytruda

July 5, 2018

Antibe reports secondary endpoint data from phase IIb GI safety study of ATB-346

July 5, 2018

Mitsubishi Tanabe studies MT-7117 in phase II for erythropoietic protoporphyria

July 5, 2018

TLR7 agonists presented by Apros Therapeutics

July 5, 2018

Roche initiates phase I study of RO-7172508 in CEA-positive solid tumors

July 5, 2018

Sumitomo Dainippon seeks Japanese approval for thiotepa as pre-HSCT conditioning treatment

July 5, 2018

Shenzhen Targetrx Biotechnology presents EGFR mutant inhibitors

July 5, 2018

Sanofi and Lead Pharma Holding patent RORC modulators

July 5, 2018

Celtaxsys divulges new LTA-4 hydrolase inhibitors

July 5, 2018

Introducing BioWorld Science: supporting R&D decisions through drug discovery and preclinical news

July 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...